Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2026)
Vir Biotechnology (VIR) reported Goodwill & Intangibles of $24.7 million for Q1 2026, down 1.18% on a YoY basis from $25.0 million in Q1 2025, and little changed sequentially from $24.8 million in Q4 2025.
Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Goodwill & Intangibles data on file, last reported at $24.7 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 1.18% year-over-year to $24.7 million; the trailing twelve-month figure through Mar 2026 stood at $24.7 million (down 1.18% YoY), and the FY2025 full-year result was $24.8 million, down 1.08% from the prior year.
- Goodwill & Intangibles steadied at $24.7 million in Q1 2026, from $24.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $50.1 million in Q1 2022 to a low of $24.7 million in Q1 2026.
- A 5-year average of $37.3 million and a median of $39.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles slipped 1.05% in 2022 and slumped 36.57% in 2024, its largest moves.
- Tracing VIR's Goodwill & Intangibles over 5 years: stood at $49.7 million in 2022, then declined by 20.51% to $39.5 million in 2023, then slumped by 36.57% to $25.1 million in 2024, then decreased by 1.08% to $24.8 million in 2025, then decreased by 0.29% to $24.7 million in 2026.
- Business Quant data shows VIR's Goodwill & Intangibles at $24.7 million in Q1 2026, $24.8 million in Q4 2025, and $24.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.71 Mn |
| Dec 31, 2025 | 24.79 Mn |
| Sep 30, 2025 | 24.86 Mn |
| Jun 30, 2025 | 24.94 Mn |
| Mar 31, 2025 | 25.01 Mn |
| Dec 31, 2024 | 25.06 Mn |
| Sep 30, 2024 | 36.20 Mn |
| Jun 30, 2024 | 35.84 Mn |
| Mar 31, 2024 | 39.40 Mn |
| Dec 31, 2023 | 39.50 Mn |
| Sep 30, 2023 | 42.39 Mn |
| Jun 30, 2023 | 42.53 Mn |
| Mar 31, 2023 | 49.56 Mn |
| Dec 31, 2022 | 49.69 Mn |
| Sep 30, 2022 | 49.83 Mn |
| Jun 30, 2022 | 49.96 Mn |
| Mar 31, 2022 | 50.09 Mn |
| Dec 31, 2021 | 50.22 Mn |
| Sep 30, 2021 | 50.36 Mn |
| Jun 30, 2021 | 50.49 Mn |